Nyxoah SA
XBRU:NYXH

Watchlist Manager
Nyxoah SA Logo
Nyxoah SA
XBRU:NYXH
Watchlist
Price: 8.1 EUR 3.58% Market Closed
Market Cap: 278.3m EUR
Have any thoughts about
Nyxoah SA?
Write Note

Nyxoah SA
Investor Relations

Nyxoah SA engages in the research and development, manufacture and sale of medical devices. The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 72 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Robert Taub MBA
Co-Founder & Chairman
No Bio Available
Mr. Olivier Taelman
CEO & Executive Director
No Bio Available
Mr. Loic Moreau
President of International
No Bio Available
Mr. John Landry
Chief Financial Officer
No Bio Available
Mr. Bruno Onkelinx
Chief Technology Officer
No Bio Available
Mikaela Kirkwood
Corporate Communication & Investor Relations Manager
No Bio Available
Ms. An Moonen
General Counsel
No Bio Available
Ms. Maggie McGowan
Chief HR Officer
No Bio Available
Mr. Remi Renard
Chief of Staff
No Bio Available
Mr. Jeyakumar Subbaroyan
Chief Clinical Officer
No Bio Available

Contacts

Address
BRABANT-WALLON
Mont-Saint-Guibert
Rue Edouard Belin 12
Contacts
+3226121755.0
www.nyxoah.com